Zevra Therapeutics (FRA:1GDA) Current Accrued Expense : €11.82 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Zevra Therapeutics Current Accrued Expense?

Zevra Therapeutics's Current Accrued Expense for the quarter that ended in Dec. 2024 was €11.82 Mil.

Zevra Therapeutics's quarterly Current Accrued Expense increased from Jun. 2024 (€19.00 Mil) to Sep. 2024 (€22.04 Mil) but then declined from Sep. 2024 (€22.04 Mil) to Dec. 2024 (€11.82 Mil).

Zevra Therapeutics's annual Current Accrued Expense increased from Dec. 2022 (€2.42 Mil) to Dec. 2023 (€13.22 Mil) but then declined from Dec. 2023 (€13.22 Mil) to Dec. 2024 (€11.82 Mil).

Zevra Therapeutics Current Accrued Expense Historical Data

The historical data trend for Zevra Therapeutics's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zevra Therapeutics Current Accrued Expense Chart

Zevra Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Current Accrued Expense

Get a 7-Day Free Trial

4.50

2.23

2.42

13.22

11.82

Zevra Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Current Accrued Expense	Get a 7-Day Free Trial															13.22	20.96	19.00	22.04	11.82

Zevra Therapeutics Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Zevra Therapeutics Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Zevra Therapeutics's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Zevra Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zevra Therapeutics Inc (FRA:1GDA) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

ZVRA:USA 1GDA:Germany

Address

1180 Celebration Boulevard, Suite 103, Celebration, FL, USA, 34747

Website

https://www.zevra.com

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Zevra Therapeutics Headlines

No Headlines